Neurochemical Research

, Volume 32, Issue 4, pp 739–750

Alzheimer’s Disease and Cholesterol: The Fat Connection

Original Paper

DOI: 10.1007/s11064-006-9200-1

Cite this article as:
Canevari, L. & Clark, J.B. Neurochem Res (2007) 32: 739. doi:10.1007/s11064-006-9200-1


Since the discovery of the significance of the cholesterol-carrying apolipoprotein E and cholesterolaemia as major risk factors for Alzheimer’s Disease (AD) there has been a mounting interest in the role of this lipid as a possible pathogenic agent. In this review we analyse the current evidence linking cholesterol metabolism and regulation in the CNS with the known mechanisms underlying the development of Alzheimer’s Disease. Cholesterol is known to affect amyloid-β generation and toxicity, although it must be considered that the results studies using the statin class of drugs to lower plasma cholesterol may be affected by other effects associated with these drugs. Finally, we report some of our results pointing at the interplay between neurons and astrocytes and NADPH oxidase activation as a new candidate mechanism linking cholesterol and AD pathology.


Alzheimer’s Disease, Amyloid-beta, Cholesterol, Statins, ApoE, NADPH oxidase 

Copyright information

© Springer Science+Business Media, LLC 2006

Authors and Affiliations

  1. 1.Miriam Marks Division of Neurochemistry, Department of Molecular Neuroscience, Institute of NeurologyUniversity College LondonLondonUK
  2. 2.Department of Cellular and Molecular Neuroscience, Division of Neuroscience and Mental HealthImperial CollegeLondonUK

Personalised recommendations